Literature DB >> 24421038

Gut adhesive Bacillus subtilis spores as a platform for mucosal delivery of antigens.

Milene Tavares Batista1, Renata D Souza, Juliano D Paccez, Wilson B Luiz, Ewerton L Ferreira, Rafael C M Cavalcante, Rita C C Ferreira, Luís C S Ferreira.   

Abstract

Bacillus subtilis spores have been used as safe and heat-resistant antigen delivery vectors. Nonetheless, the oral administration of spores typically induces weak immune responses to the passenger antigens, which may be attributed to the fast transit through the gastrointestinal tract. To overcome this limitation, we have developed B. subtilis spores capable of binding to the gut epithelium by means of expressing bacterial adhesins on the spore surface. The resulting spores bound to in vitro intestinal cells, showed a longer transit through the mouse intestinal tract, and interacted with Peyer's patch cells. The adhesive spores increased the systemic and secreted antibody responses to the Streptococcus mutans P1 protein, used as a model antigen, following oral, intranasal, and sublingual administration. Additionally, P1-specific antibodies efficiently inhibited the adhesion of the oral pathogen Streptococcus mutans to abiotic surfaces. These results support the use of gut-colonizing B. subtilis spores as a new platform for the mucosal delivery of vaccine antigens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24421038      PMCID: PMC3993416          DOI: 10.1128/IAI.01255-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The FtsH protein accumulates at the septum of Bacillus subtilis during cell division and sporulation.

Authors:  W Wehrl; M Niederweis; W Schumann
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

2.  Bacterial spores as vaccine vehicles.

Authors:  Le H Duc; Huynh A Hong; Neil Fairweather; Ezio Ricca; Simon M Cutting
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 3.  Recombinant bacterial vaccines.

Authors:  Meera Unnikrishnan; Rino Rappuoli; Davide Serruto
Journal:  Curr Opin Immunol       Date:  2012-04-26       Impact factor: 7.486

4.  Surface display of the receptor-binding region of the Lactobacillus brevis S-layer protein in Lactococcus lactis provides nonadhesive lactococci with the ability to adhere to intestinal epithelial cells.

Authors:  Silja Avall-Jääskeläinen; Agneta Lindholm; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

5.  Surface display of recombinant proteins on Bacillus subtilis spores.

Authors:  R Isticato; G Cangiano; H T Tran; A Ciabattini; D Medaglini; M R Oggioni; M De Felice; G Pozzi; E Ricca
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

6.  Fate and dissemination of Bacillus subtilis spores in a murine model.

Authors:  T T Hoa; L H Duc; R Isticato; L Baccigalupi; E Ricca; P H Van; S M Cutting
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

7.  Surface display of foreign epitopes on the Lactobacillus brevis S-layer.

Authors:  Silja Avall-Jääskeläinen; Kari Kylä-Nikkilä; Minna Kahala; Terhi Miikkulainen-Lahti; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

8.  Identification by flagellum display of an epithelial cell- and fibronectin-binding function in the SlpA surface protein of Lactobacillus brevis.

Authors:  Ulla Hynönen; Benita Westerlund-Wikström; Airi Palva; Timo K Korhonen
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

9.  Intracellular fate and immunogenicity of B. subtilis spores.

Authors:  Le H Duc; Huynh A Hong; Nguyen Q Uyen; Simon M Cutting
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641

10.  Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner.

Authors:  Emilia M F Mauriello; Le H Duc; Rachele Isticato; Giuseppina Cangiano; Huynh A Hong; Maurilio De Felice; Ezio Ricca; Simon M Cutting
Journal:  Vaccine       Date:  2004-03-12       Impact factor: 3.641

View more
  16 in total

1.  The storage stability of Bacillus subtilis spore displaying cysteine protease of Clonorchis sinensis and its effect on improving the gut microbiota of mice.

Authors:  Zeli Tang; Zhanshuai Wu; Hengchang Sun; Lu Zhao; Mei Shang; Mengchen Shi; Hongye Jiang; Zhipeng Lin; Xinyi Zhou; Xuerong Li; Xinbing Yu; Yan Huang
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-19       Impact factor: 4.813

2.  Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of the Streptococcus mutans P1 surface protein.

Authors:  Milene Tavares Batista; Renata D Souza; Ewerton L Ferreira; Rebekah Robinette; Paula J Crowley; Juliana F Rodrigues; L Jeannine Brady; Luís C S Ferreira; Rita C C Ferreira
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

3.  Effect of oral administration of Bacillus coagulans B37 and Bacillus pumilus B9 strains on fecal coliforms, Lactobacillus and Bacillus spp. in rat animal model.

Authors:  Lopamudra Haldar; D N Gandhi
Journal:  Vet World       Date:  2016-07-26

4.  The immunological characteristics and probiotic function of recombinant Bacillus subtilis spore expressing Clonorchis sinensis cysteine protease.

Authors:  Zeli Tang; Mei Shang; Tingjin Chen; Pengli Ren; Hengchang Sun; Hongling Qu; Zhipeng Lin; Lina Zhou; Jinyun Yu; Hongye Jiang; Xinyi Zhou; Xuerong Li; Yan Huang; Jin Xu; Xinbing Yu
Journal:  Parasit Vectors       Date:  2016-12-19       Impact factor: 3.876

5.  Genetic Competence Drives Genome Diversity in Bacillus subtilis.

Authors:  Patrícia H Brito; Bastien Chevreux; Cláudia R Serra; Ghislain Schyns; Adriano O Henriques; José B Pereira-Leal
Journal:  Genome Biol Evol       Date:  2018-01-01       Impact factor: 3.416

6.  4,4'-Diaponeurosporene-Producing Bacillus subtilis Increased Mouse Resistance against Salmonella typhimurium Infection in a CD36-Dependent Manner.

Authors:  Haofei Liu; Wenwen Xu; Qinghua Yu; Qian Yang
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

7.  Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin.

Authors:  Alastair Copland; Gil R Diogo; Peter Hart; Shane Harris; Andy C Tran; Mathew J Paul; Mahavir Singh; Simon M Cutting; Rajko Reljic
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

8.  Bacillus subtilis spore with surface display of paramyosin from Clonorchis sinensis potentializes a promising oral vaccine candidate.

Authors:  Hengchang Sun; Zhipeng Lin; Lu Zhao; Tingjin Chen; Mei Shang; Hongye Jiang; Zeli Tang; Xinyi Zhou; Mengchen Shi; Lina Zhou; Pengli Ren; Honglin Qu; Jinsi Lin; Xuerong Li; Jin Xu; Yan Huang; Xinbing Yu
Journal:  Parasit Vectors       Date:  2018-03-07       Impact factor: 3.876

9.  Alternative use of Bacillus subtilis spores: protection against environmental oxidative stress in human normal keratinocytes.

Authors:  Ganna Petruk; Giuliana Donadio; Mariamichela Lanzilli; Rachele Isticato; Daria Maria Monti
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

Review 10.  Buccal and sublingual vaccine delivery.

Authors:  Heleen Kraan; Hilde Vrieling; Cecil Czerkinsky; Wim Jiskoot; Gideon Kersten; Jean-Pierre Amorij
Journal:  J Control Release       Date:  2014-06-06       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.